All Articles

Positive early human safety data for its lead drug and new candidates for Rett syndrome and MASH signal a pivotal year for ProQR's Axiomer technology.

A new national reimbursement code for NeurAxis's IB-Stim therapy is set to revolutionize access for chronic GI pain patients, validating the technology.

A new partnership brings revolutionary 3D genome mapping from the lab to the clinic, offering new hope for patients with hard-to-treat cancers.

A new survey shows no firm recovers from cyberattacks in a day, with downtime lasting weeks. Yet, executive focus on resilience may be dangerously waning.

Sunwoda deepens its Sungrow alliance, unveiling advanced battery tech and a robust ESG strategy to lead the global clean energy transition.

After 30 years, CEO Jim Foster will retire, passing the torch to COO Birgit Girshick in a move that signals continuity and a new era of governance.

Klotho Neurosciences will present its novel gene therapy for Alzheimer's and ALS at a key summit, seeking to turn scientific promise into clinical reality.

Pan Global Resources has defined a major copper and gold resource in Spain, fueling the green energy transition and reviving a historic mining district.

As household debt soars, Ramsey Solutions relaunches its EveryDollar app with AI tools and live coaching, aiming for a $20 billion annual impact.

Internet outages cost restaurants thousands. Bigleaf Networks' new 'Connected Kitchen' podcast explores how to build resilient networks and protect profits.

A new partnership aims to bring cutting-edge cancer trials to community clinics, accelerating drug development and expanding patient access to care.

858 Therapeutics' novel PARG inhibitor offers new hope for patients with a deadly, drug-resistant form of ovarian cancer, accelerating its path to approval.

Accenture's new investment in Profitmind's agentic AI platform signals a major shift for retail, promising to automate complex decisions and bridge the gap between data and action.

A new report challenges raid-focused tactics, using survivor stories to offer a blueprint for preventing exploitation in America's illicit massage industry.

The new x-hoppers mobile app bridges the gap between the frontline and back office, creating a unified, AI-powered communication network for all staff.

The Spanish epigenetics leader will showcase its advanced CNS and oncology pipeline at key January conferences, seeking partners and investor validation.

With a potential winter drill program at its Tharsis REE project and high-grade results at Big Mack, the company is advancing two key Canadian assets.

A new study on a compact, wireless robotic device could democratize access to precision knee surgery, thanks to pioneering work from a rural Missouri surgeon.

Collegium Pharmaceutical projects robust 2026 revenue fueled by its ADHD drug Jornay PM, savvy debt refinancing, and a proactive generic strategy.

Echo Water's new Echo One promises ultra-pure, hydrogen-rich water on demand. But is the cutting-edge science and technology worth the premium price tag?